Citigroup
AEMD icon

Citigroup’s Aethlon Medical AEMD Stock Holding History

Citigroup’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33
Closed -$91 – 5905
2025
Q4 		$91 Sell
33
-213
-87% -$990 ﹤0.01% 5671
2025
Q3 		$1.84K Buy
+246
New +$2.83K ﹤0.01% 5503
2024
Q4 		– Sell
-31
Closed -$1.16K – 5814
2024
Q3 		$1.16K Buy
+31
New +$985 ﹤0.01% 5442
2022
Q3 		– Sell
-9
Closed -$8K – 5780
2022
Q2 		$8K Buy
+9
New +$8.38K ﹤0.01% 5436

Other funds holding AEMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Citigroup's AEMD Position: Q1 2026 in Review

Citigroup sold out of Aethlon Medical (AEMD) in Q1 2026, closing a stake of 33 shares — an estimated $91 sold.

Citigroup first reported a position in AEMD in Q2 2022 and held it in 4 quarters. The position peaked at $8K in Q2 2022. 12 funds tracked by Wall St. Rank hold AEMD as of Q1 2026.

  • Citigroup reported no remaining Aethlon Medical position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 33 Aethlon Medical shares in Q1 2026, an estimated $91.
  • Citigroup first reported a position in Aethlon Medical in Q2 2022 and held it in 4 quarters.
  • Citigroup's Aethlon Medical position peaked at $8K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.